Project cooperationUpdated on 15 May 2025
HORIZON-MISS-2025-02-CANCER-03: Innovative surgery for affordable multi-modal therapies in locally advanced/metastatic cancer patients
About
-
Preoperative therapy combining hyperthermia and cisplatin aims to shrink tumors, reduce recurrence risk, and improve surgical outcomes in colorectal cancer. Limitations of current Therapy -
-
Systemic toxicity**:** Nephrotoxicity and hematological complications from cisplatin exposure.
-
Inconsistent drug uptake: Physiological barriers limit tumor penetration.
-
Heat-induced resistance: Some cancer cells develop thermotolerance.
Nanotechnologies are designed to enhance this approach by optimizing drug delivery, minimizing toxicity, and amplifying therapeutic efficacy.
Topic
- Cancer Mission: HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
TCancer (HORIZON-MISS-2025-02-CANCER-02: EU Cancer Mission)
- Consortium/Coordinator seeks Partners
- Cancer Mission: HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
Sonata Jarmalaite
Deputy Director Reserch & Development at National Cancer Institute
Vilnius, Lithuania
Project cooperation
Partnering for Data-Driven Pediatric Cancer Research on Environmental Risk Factors
- Partner seeks Consortium/Coordinator
- Cancer Mission: HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
Anna Król
Data Science Department Director at Saving Kids With Cancer Foundation
Wrocław, Poland
Project cooperation
Uncovering Environmental Drivers of Cancer Risk in Children, Adolescents, and Young Adults
- Partner seeks Consortium/Coordinator
- Cancer Mission: HORIZON-MISS-2025-02-CANCER-02: Understanding the effects of environmental exposure on the risk of paediatric, adolescent and young adult cancers
Lolita Rapoliene
Prof. at Klaipeda University
Klaipeda, Lithuania